Medications Updated During 2014, From Newest to Oldest, Page 15

Page 15 of 330 « First Page « … 5 10 … 13 14 15 16 17 … 20 25 30 35 40 … » Last Page »

Eprosartan Mesylate

Eprosartan mesylate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensives such as diuretics and calcium channel blockers. CONTRAINDICATIONS: Eprosartan mesylate tablets are…

Mylan Pharmaceuticals Inc.5 December 2014

Paroxetine

Major Depressive Disorder. Paroxetine tablets USP is indicated for the treatment of major depressive disorder. The efficacy of paroxetine tablets USP in the treatment of a major depressive episode was established in 6-week controlled trials of…

Caraco Pharmaceutical Laboratories, Ltd.5 December 2014

MEDI-FLEXX RX JOINT SUPPORT FORMULA (GLUCOSAMINE SULFATE CHONDROITIN SULFATE (BOVINE) DIMETHYL SULFONE)

WARNING: CONSULT YOUR PHYSICIAN BEFORE USING THIS PRODUCT IF YOU ARE PREGNANT. LACTATING. OR ARE BEING TREATED FOR A SERIOUS MEDICAL CONDITION. KEEP OUT OF REACH OF CHILDREN. STORE IN A COOL. DRY PLACE. IF SEAL IS BROKEN. DO NOT USE. MEDI-FLEXX…

Two Hip Consulting, LLC5 December 2014

MEDI-LAXX RX STOOL SOFTENER AND LAXATIVE (DOCUSATE SODIUM SENNOSIDES)

AMOUNT PER SERVING. DOCUSATE SODIUM 50 MG. SENNOSIDES (SENNA) 8.6 MG. AS A DIETARY SUPPLEMENT. TAKE 1 TABLET BEFORE MEAL TWICE A DAY. Medi-Sulting-Medi-Laxx. Label-Final.

Two Hip Consulting, LLC5 December 2014

Venlafaxine Hydrochloride

Venlafaxine Hydrochloride Extended-Release Capsules USP are indicated for the treatment of major depressive disorder. The efficacy of Venlafaxine Hydrochloride Extended-Release Capsules USP in the treatment of major depressive disorder was…

RxChange Co.5 December 2014

Page 15 of 330 « First Page « … 5 10 … 13 14 15 16 17 … 20 25 30 35 40 … » Last Page »

FDA Medwatch

CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets
Tue, 07 Jul 2020. As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing. This testing revealed that some…
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Tue, 07 Jul 2020. Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA,…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.